Gates Marcus, Mallory Grant, Planchard Ryan, Nothdurft Georgia, Graffeo Christopher, Atkinson John
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
World Neurosurg. 2017 Apr;100:417-423. doi: 10.1016/j.wneu.2017.01.046. Epub 2017 Jan 24.
Isolated traumatic subarachnoid hemorrhage (iTSAH) in mild head injuries has more evidence that triage to a tertiary care facility, intensive care unit admission, and repeat imaging is not warranted. Certain factors were identified that predict radiographic and clinical progression in hopes of preventing avoidable cost, which occur with transfer and subsequent management.
A retrospective analysis identified 67 patients transferred between January 2010 and December 2014 who met inclusion criteria. Primary outcomes assessing neurosurgical intervention, radiographic, and clinical progression were documented. Secondary outcomes included any operative intervention, length of stay, standardized hospital costs, disposition at discharge, and 30-day mortality.
The mean age of the cohort was 67.7 ± 16.4 years, with most patients (82.1%) having a Glasgow coma score of 15. Warfarin was used in 10 patients (14.9%), although 55.2% were on an antiplatelet or anticoagulation agent. No patient required neurosurgical intervention. One patient, on clopidogrel (Plavix) and warfarin, neurologically declined with radiographic progression. Older age seem to correlate with radiographic progression (P = 0.05). Dementia (P = 0.05) as well as warfarin use (P = 0.06) correlated with clinical progression. Cost in patients without other injuries was associated with warfarin use (P = 0.0002), injury severity scores (P = 0.01), and initial Glasgow coma score (P = 0.0003) on multivariate analysis.
In this series of patients with mild traumatic brain injury, the rate of neurological deterioration due to expansion of iTSAH in patients is low, regardless of the use of antiplatelets/anticoagulants. Triage to a tertiary care facility generally is not warranted and can prove costly to patients with iTSAH without other injures.
轻度头部损伤中的孤立性创伤性蛛网膜下腔出血(iTSAH)有更多证据表明,将患者分诊至三级医疗机构、收入重症监护病房以及进行重复影像学检查并无必要。已确定某些因素可预测影像学和临床进展,以期避免因转运及后续管理而产生的可避免费用。
一项回顾性分析确定了2010年1月至2014年12月期间转诊且符合纳入标准的67例患者。记录了评估神经外科干预、影像学及临床进展的主要结局。次要结局包括任何手术干预、住院时间、标准化住院费用、出院处置情况及30天死亡率。
该队列患者的平均年龄为67.7±16.4岁,大多数患者(82.1%)格拉斯哥昏迷评分为15分。10例患者(14.9%)使用了华法林,不过55.2%的患者正在使用抗血小板药物或抗凝剂。无患者需要神经外科干预。1例服用氯吡格雷(波立维)和华法林的患者出现神经功能衰退且伴有影像学进展。年龄较大似乎与影像学进展相关(P = 0.05)。痴呆(P = 0.05)以及使用华法林(P = 0.06)与临床进展相关。多因素分析显示,无其他损伤患者的费用与使用华法林(P = 0.0002)、损伤严重程度评分(P = 0.01)及初始格拉斯哥昏迷评分(P = 0.0003)相关。
在这组轻度创伤性脑损伤患者中,无论是否使用抗血小板药物/抗凝剂,因iTSAH扩大导致神经功能恶化的发生率都较低。一般无需将iTSAH且无其他损伤的患者分诊至三级医疗机构,这可能会给患者带来高昂费用。